Macrogenics (MGNX) Provides Update on Corporate Progress, TAMARACK Phase 2 Study Data, Q1 Results

Go back to Macrogenics (MGNX) Provides Update on Corporate Progress, TAMARACK Phase 2 Study Data, Q1 Results
MACROGENICS (NASDAQ: MGNX) Delayed: 4.14 +0.01 (0.24%)
Previous Close $4.13    52 Week High $36.11 
Open $4.12    52 Week Low $14.84 
Day High $4.17    P/E 10.62 
Day Low $4.09    EPS $0.39 
Volume 873,939